Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2007-12-06
2010-06-08
Belyavskyi, Michail A (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S577000, C435S326000, C435S346000, C435S372000
Reexamination Certificate
active
07731969
ABSTRACT:
Disclosed are methods for producing immortalized antigen-specific plasma cells and antibodies which include depleting an immunized cell population of CD138-positive cells and activating the depleted cells. The methods may be used to improve the efficiency of obtaining immortalized antigen-specific plasma cells.
REFERENCES:
patent: 5244656 (1993-09-01), Risser et al.
patent: 5705150 (1998-01-01), Risser et al.
Arce, Sergio et al; CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations; Journal of Leukocyte Biology; vol. 75, Jun. 2004; pp. 1022-1028.
Bovia, Fabrice et al, Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors; Blood, Mar. 1, 2003; vol. 101, No. 5, pp. 1727-1733.
Driver, David J. et al; Development and Maintenance of a B220- Memory B Cell Compartment; The Journal of Immunology, 2001; vol. 167; pp. 1393-1405.
Ettinger, Rachel et al; IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells; The Journal of Immunology, 2005; vol. 176; pp. 7867-7879.
Hasbold, Jhagvaral et al; Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulat lymphocyte differentiation; Nature Immunology, Jan. 2004; vol. 5, No. 1: pp. 55-63.
Hathcock, Karen S. et al; Expression of Different CD45 Isoforms by Subpopulations of Activated B Cells; The Journal of Immunology; Oct. 1, 1992; vol. 149, No. 7, pp. 2286-2294.
Hausl, Christina et al; Long-term Persistence of Anti-factor VIII Antibody-secreting Cells in Hemophilic Mice after Treatment with Human Factor VIII; Thromb Haemost, 2002; vol. 87; pp. 840-845.
Hausl, Christina et al; Preventing restimulation of memory B cells in hemophilia A; a potential new strategy for the treatment of antibody-dependent immune disorders; Blood; Jul. 1, 2004; vol. 104, No. 1, pp. 115-122.
Hausl, Christina et al; High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors; Blood; Nov. 15, 2005; vol. 106, No. 10, pp. 3415-3422.
Kodituwakku, Aruna P. et al; Isolation of antigen-specific B cells; Immunology and Cell Biology; 2003, vol. 81;pp. 163-170.
Kwekkeboom, J. et al; CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells; Immunology; 1993; vol. 79, pp. 439-444.
Largaespada, David A. et al; The ABL-MYC retrovirus generates antigen-specific plasmacytomas by in vitro infection of activated B lymphocytes from spleen and other murine lymphoid organs; Journal of Immunological Methods; vol. 197; 1996, pp. 85-95.
McHeyzer-Williams, Louise J. et al; Antigen-specific B Cell Memory: Expression and Replenishment of a Novel B220- Memory B Cell Compartment; J. Exp. Med., Apr. 3, 2000; vol. 191, No. 7, pp. 1149-1165.
Ohno, Shinsuke et al; Chromosomal Translocations Activating myc Sequences and Tranduction of v-abl Are Critical Events in the Rapid Induction of Plasmacytomas by Pristane and Abelson Virus; Journal of Experimental Medicine; Jun. 1984; vol. 159; pp. 1762-1777.
Ozaki, Katsutoshi et al; Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6; The Journal of Immunology; 2004; vol. 173, pp. 5361-5371.
Potter, Michael; Neoplastic developent in plasma cells; Immunological Reviews, 2003, vol. 194, pp. 177-195.
Ridderstad, Anna et al; The xid Mutation Diminishes Memory B Cell Generation but Does Not Affect Somatic Hypermutation and Selection; The Journal of Immunology, 1996; vol. 157, pp. 3357-3365.
Sanderson, Ralph D. et al; B lumphocytes express and lose syndecan at specific stages of differentiation; Cell Regulation, Nov. 1989; vol. 1, pp. 27-35.
Shapiro-Shelef, Miriam et al; Blimp-1 Is Required for the Formation of Immunoglobulin Secreting Plasma Cells and Pre-Plasma Memory B Cells; Immunity, Oct. 2003; vol. 19, pp. 607-620.
Shapiro-Shelef, Miriam et al; Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow; The Journal of Experimental Medicine; Dec. 5, 2005; vol. 202, No. 11, pp. 1471-1476.
Smith, Kenneth G.C. et al; The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response; The EMBO Journal, 1997; vol. 16, No. 11, pp. 2996-3006.
Snapper, Clifford M. et al; Interferon-# and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production; Science, May 22, 1987; vol. 236, No. 4804, pp. 944-947.
Sze, Daniel M.-Y. et al; Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival; J. Exp. Med., Sep. 18, 2000; vol. 192, No. 6, pp. 813-821.
Tonkonogy, Susan L. et al; Effects of Lymphokines on Ig Production Depend on the State of Activation of the Responding B Cells; The Journal of Immunology; Jun. 15, 1989; vol. 142, No. 12, pp. 4351-4360.
Tucci, Alessandra et al; Effects of Eleven Cytokines and of IL-1 and Tumor Necrosis Factor Inhibitors in a Human B Cell Assay; The Journal of Immunology; May 1, 1992; vol. 148, No. 9, pp. 2778-2784.
Weissinger, Eva M. et al; Induction of plasmacytomas secreting antigen-specific monocloncal antibodies with a retrovirus expressing v-abl and c-myc; Proc. Natl. Acad. Immunology, Oct. 1991, vol. 88, pp. 8735-8739.
Werner-Favre, Christiane et al; IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD +IgM+, post-germinal center (CD27*) human Be cells; Eur. J. Immunology; 2001, vol. 31, pp. 243-249.
Whitehead, Ian et al; Expression Cloning of Oncogenes by Retroviral Transfer of cDNA Libraries; Molecular and Cellular Biology; Feb. 1995; vol. 15, No. 2, pp. 704-710.
Wiener, Francis et al; Nonrandom Chromsomal Change (Trisomy 11) in Murine Plasmacytomas Induced by an ABL-MYC Retrovirus; Cancer Research, Mar. 1, 1995; vol. 55, pp. 1181-1188.
Zhang, Xiaohong et al; IL-4-Dependent IgE Switch in Membrane IgA-Positive Human B Cells; The Journal of Immunology; Nov. 1, 1991; vol. 147, No. 9, pp. 3001-3004.
Zubler, Rudolf H. et al; Mutant EL-4 Thymoma Cells Polycloncally Activate Murine and Human B Cells Via Direct Cell Interaction; The Journal of Immunology; Jun. 1985; vol. 134, No. 6, pp. 3662-3668.
Lalor, Paul A. et al; Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)- specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP*; Eur. J. Immunol. 1992, vol. 22, pp. 3001-3011.
Jackson Mark W.
Kravitz Rachel H.
Tucker Ward C.
Andrus Sceales Starke & Sawall LLP
Belyavskyi Michail A
NeoClone Biotechnology International, LLC
LandOfFree
Methods for developing and producing antigen-specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for developing and producing antigen-specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for developing and producing antigen-specific... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222075